Close

Analyst Ratings for Edgewise Therapeutics (EWTX) [Sells]

EWTX Rating Summary

EWTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on EWTX
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $30.40 (+88.7%) * Over Last 12-Mos
Rating Score: 8.6 / 10   Percentile Rank: 88%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/25/2022 Goldman Sachs Madhu Kumar Downgrade Sell
(Neutral)
5.00
(N/A)
10.80
(16.11)
49.17% Details